VHL deficiency can activate the NF‐κB pathway,133 which in turn induces the expression of antiapoptotic genes Bcl‐xL and Bcl‐2 and suppresses the expression of tumor suppressor genes (such as p53), suggesting its potential role in the development of renal cancer.129, 134. The gene discussed is TP53; the disease is renal carcinoma.